Pioneering Precision Diagnostics for Antibiotic Treatment and Sepsis Care – The Role of Rapid AST
Sepsis affects up to 50 million people annually and is the number one cause of death in hospitals worldwide. Adding to this crisis, the global rise in antibiotic resistance is undermining the ability to effectively combat sepsis. The World Health Organisation has stressed the urgent need for new diagnostic tools to guide appropriate antibiotic treatment and reduce the misuse of antibiotics.
In this webinar, join Dr. Kevin Alby, University of North Carolina at Chapel Hill, Dr. Matthew Faron Medical College Wisconsin and Dr. Christer Malmberg, Gradientech, as they share valuable insights and explore innovative tools that have the potential to transform sepsis management and save countless lives.They will also discuss the latest data on novel rapid antimicrobial susceptibility testing (AST) solutions, including QuickMIC®, an ultra-rapid AST system delivering MIC values in just 2–4 hours.
Key learning objectives
- Learn about emerging technologies within rapid antimicrobial susceptibility testing (AST) and their value to clinical microbiology labs
- Gain an understanding of how rapid AST methods are being used to combat sepsis and antimicrobial resistance (AMR)
- Discover the impact rapid AST can have on patient care, ensuring the right person receives the right treatment at the right time
Who should attend?
- Microbiologists
- Infectious disease clinicians
- Professionals working within clinical microbiology
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
